Pneumonia Vaccine Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Pneumonia Vaccine Market covers analysis By Vaccine Type (Pneumococcal Polysaccharide Vaccine (PPSV/PPV), Pneumococcal Conjugate Vaccine (PCV)) ; Product Type (Prevnar 13, Synflorix, Pneumovax23) ; Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00008672
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Pneumonia Vaccine Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET INTRODUCTION

Pneumonia is one of the types of lung infection which is caused due to bacteria, viruses, and fungi. Infants below two years and people over age 65 are highly vulnerable for pneumonia. Additionally, certain habits such as smoking, excessive alcoholism, and lifestyle habits are responsible to cause pneumonia. Chest pain while breathing, nausea, vomiting, shortness of breath, fatigue, and fever are some of the indications of observed in pneumonia.

MARKET DYNAMICS

Increasing prevalence of pneumonia amongst the population is likely to drive the growth of the pneumonia vaccines market during the forecast period. Moreover, aging population coupled with excessive alcoholism is also directly have impact on growth of the pneumonia patients, which will in turn anticipated to drive the market growth.

MARKET SCOPE

The "Pneumonia Vaccine Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Pneumonia Vaccine Market with detailed market segmentation by vaccine type, product type, distribution channel and geography. The Pneumonia Vaccine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Pneumonia Vaccine Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Pneumonia Vaccine Market is segmented on the basis by vaccine type, product type, and distribution channel. Based on vaccine type, the market is segmented into pneumococcal polysaccharide vaccine (PPSV/PPV) and pneumococcal conjugate vaccine (PCV). On the basis of product type, the market is segmented as Prevnar 13, Synflorix, and Pneumovax23. ON the basis on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and others.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Pneumonia Vaccine Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pneumonia Vaccine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Pneumonia Vaccine Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pneumonia Vaccine Market in these regions.


Pneumonia Vaccine Market Report Analysis

Pneumonia Vaccine Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Pfizer
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Vaccine Type [Pneumococcal Polysaccharide Vaccine
  • PPSV/PPV
  • Pneumococcal Conjugate Vaccine
By Product Type
  • Prevnar 13
  • Synflorix
  • Pneumovax23
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the Pneumonia Vaccine Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pneumonia Vaccine Market are anticipated to lucrative growth opportunities in the future with the rising demand for Pneumonia Vaccine Market in the global market. Below mentioned is the list of few companies engaged in the Pneumonia Vaccine Market.

The report also includes the profiles of key Pneumonia Vaccine Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Pfizer
- GlaxoSmithKline plc.
- Merck & Co., Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Pneumonia Vaccine Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Vaccine Type [Pneumococcal Polysaccharide Vaccine
  • PPSV/PPV
  • Pneumococcal Conjugate Vaccine
By Product Type
  • Prevnar 13
  • Synflorix
  • Pneumovax23
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Pfizer
    2. GlaxoSmithKline plc.
    3. Merck & Co., Inc.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..